EAM
QTTB icon

Eventide Asset Management’s Q32 Bio QTTB Stock Holding History

Eventide Asset Management’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-190,000
Closed -$8.48M – 221
2024
Q3 		$8.48M Buy
+190,000
New +$6.98M 0.15% 130

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Eventide Asset Management's QTTB Position: Q4 2024 in Review

Eventide Asset Management sold out of Q32 Bio (QTTB) in Q4 2024, closing a stake of 190,000 shares — an estimated $8.48M sold.

Eventide Asset Management first reported a position in QTTB in Q3 2024 and held it in 1 quarter. The position peaked at $8.48M in Q3 2024. 92 funds tracked by Wall St. Rank hold QTTB as of Q4 2024.

  • Eventide Asset Management reported no remaining Q32 Bio position as of Q4 2024 after selling out during the quarter.
  • Eventide Asset Management sold 190,000 Q32 Bio shares in Q4 2024, an estimated $8.48M.
  • Eventide Asset Management first reported a position in Q32 Bio in Q3 2024 and held it in 1 quarter.
  • Eventide Asset Management's Q32 Bio position peaked at $8.48M in Q3 2024.
  • 92 funds tracked by Wall St. Rank held Q32 Bio as of Q4 2024.

Based on Eventide Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.